Skip to main content

Preclinical Assessment of GLP-1 and Combination Therapies for Obesity: Insights from Mouse Models

Published Date

Are you looking for a translationally relevant preclinical platform to evaluate therapies for Obesity and Type 2 diabetes? The JAX Metabolic Platform delivers advanced solutions for metabolic research, offering a full range of in vivo metabolic phenotyping services designed to support preclinical drug discovery and translational studies. JAX’s validated mouse models and comprehensive preclinical services support researchers in understanding the complexities of metabolic diseases. Our models facilitate the investigation of disease pathology, metabolic dysfunction, and therapeutic strategies, serving as a powerful platform for drug discovery and validation.

In this webinar, we cover:

  • Various mouse models and their utility in obesity studies
  • Study data of GLP-1 drugs in mouse models
  • Metabolic imaging and assay data guiding therapeutic strategy